Finances

Financial presentation based on MRA’s 2023 externally audited financials.
Full audit and IRS 990 are available online at CureMelanoma.org/Financials

Statement of Financial Position

ASSETS Total 2023 Total 2022
Cash and Cash Equivalents $10,055,472 $10,912,733
Investments $11,779,185 $10,877,034
Contributions Receivable (Net) $2,538,036 $5,454,387
Prepaid Expenses and Other Assets $165,962 $89,192
TOTAL ASSETS $24,538,655 $27,333,346
LIABILITIES Total 2023 Total 2022
Accounts Payable $184,366 $133,430
Grants Payable (Net) $10,848,720 $13,069,601
Deferred Revenue $497,500 $277,500
TOTAL LIABILITIES $11,530,586 $13,480,531
NET ASSETS Total 2023 Total 2022
Unrestricted $10,470,033 $12,027,815
Temporarily Restricted $2,538,036 $1,825,000
TOTAL NET ASSETS $13,008,069 $13,852,815
TOTAL LIABILITIES AND NET ASSETS $24,538,655 $27,333,346

Statement of Activities

REVENUE Total 2023 Total 2022
Contributions (Collectible Net) $4,920,205 $7,877,755
Special Events (Net) $2,806,338 $2,651,407
Sponsorship $651,705 $744,500
Interest/Investment $1,334,327 $(653,695)
In Kind Contributions $210,864 $105,762
Write-Off $(170,150) $(37,600)
Other Income $7,826 $(2,720)
TOTAL REVENUE $9,761,115 $10,685,409
EXPENSES Total 2023 Total 2022
Research Grants $6,702,128 $12,272,878
Personnel Costs $1,963,354 $2,065,037
Travel & Entertainment $503,582 $399,336
Other Expenses $562,391 $518,951
Meetings & Conferences $415,778 $251,723
Professional Fees $356,784 $332,379
Occupancy $101,844 $115,677
TOTAL EXPENSES $10,605,861 $15,955,981
NET INCOME/(LOSS) ($844,746) ($5,270,572)

Previous: 2023 Tributes & Memorials
Next: Donor Recognition